Well Referenced

Tag: Nicotinamide riboside

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD⁺ in healthy middle-aged and older adults

This 2018 randomized, double-blind, placebo-controlled, crossover trial evaluated the effects of 6 weeks of oral nicotinamide riboside (NR) supplementation (500 mg twice daily) in 24 healthy adults aged 55–79. NR significantly increased NAD⁺ levels in peripheral blood mononuclear cells by approximately 60% compared to placebo. Exploratory analyses indicated potential reductions

Read More »
June 26, 2025 No Comments

The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential

This 2021 review explores the multifaceted role of nicotinamide adenine dinucleotide (NAD⁺) in cardiovascular diseases (CVDs). NAD⁺ is integral to metabolic pathways, redox balance, and immune modulation. The article discusses how NAD⁺ influences cardiovascular health through sirtuin-dependent and independent mechanisms, affecting aging, inflammation, and oxidative stress. It highlights the potential

Read More »
June 26, 2025 No Comments